Skip to main content
. 2021 Sep 20;9(9):1272. doi: 10.3390/biomedicines9091272

Table 2.

Expression changes of the 22 miRNAs identified as deregulated by NGS, in DLB versus controls. First validation study (2017).

miRNA Expr Change 1 Dev Range 2 p-Value 3
1343-3p 0.31 0.11–0.88 0.24
191-3p 0.34 0.13–0.89 0.25
6747-3p 0.33 0.14–0.74 0.033
504-5p 0.6 0.55–0.66 0.25
6741-3p 0.32 0.16–0.66 0.17
128-3p 0.17 0.03–0.71 0.039
1468-5p 0.37 0.16–0.89 0.28
139-5p 0.26 0.09–0.69 0.029
7d-5p 0.16 0.05–0.55 0.015
7d-3p 0.34 0.12–0.95 0.21
142-3p 0.11 0.03–0.47 0.015
132-5p 0.21 0.06–0.70 0.018
150-5p 0.03 0.02–0.04 <0.0001
23a-5p 0.58 0.41–0.81 0.31
26b-5p 0.16 0.04–0.62 0.017
1301-3p 0.28 0.06–1.28 0.24
625-3p 0.32 0.07–0.41 0.14
146a-5p 0.16 0.05–0.53 0.017
25-3p 0.20 0.06–0.66 0.034
877-3p 0.34 0.14–0.84 0.22
1908-5p 0.30 0.09–094 0.21
744-5p 0.21 0.08–0.59 0.19

1 expr change, expression change obtained by the ΔΔCt method after comparing two groups; 2 dev range, deviation range of the expression change; 3 p-value obtained by the Wilcoxon–Mann–Whitney followed by Dunn’s test for multiple corrections. Significant results are highlighted in bold.